Use and effectiveness of Pioneer re-entry device for subintimal true lumen re-entry: single-centre data and a review of the literature.
IVUS
Pioneer
Re-entry device
Recanalization
Subintimal angioplasty
Journal
CVIR endovascular
ISSN: 2520-8934
Titre abrégé: CVIR Endovasc
Pays: Switzerland
ID NLM: 101738484
Informations de publication
Date de publication:
02 Dec 2021
02 Dec 2021
Historique:
received:
09
06
2021
accepted:
08
11
2021
entrez:
2
12
2021
pubmed:
3
12
2021
medline:
3
12
2021
Statut:
epublish
Résumé
During subintimal angioplasty (SIA), it is not always possible to re-enter the vessel lumen due to a variety of factors. Recanalization using hydrophilic wires and catheters alone, apart from its potential technical failure, is also limited by minimal control over the re-entry point. This is frequently well beyond the point of occlusion, thus often compromising important collaterals. In order to bypass the obstruction and attain controlled re-entry into the lumen of the diseased vessel, a re-entry device (RED) may be required. This paper assesses our centre's experience with the safety and efficacy of the Pioneer re-entry system and systematically reviews the pertinent literature. A single centre retrospective study of subintimal angioplasty involving the use of the Pioneer Plus intravascular guided reentry catheter was performed. Patient demographics including age, gender, risk factors, comorbidities clinical indication and complications were recorded. Lesion characteristics, including location and severity of calcification were also assessed. A systematic literature review of all reported studies where the Pioneer RED was used for iliac and lower limb revascularization was conducted by 2 of the authors using the PubMed (MEDLINE) and EMBASE databases. The study comprised 30 cases. Technical success was 97%. A small, quickly resolved extravasation was the only device related complication. These results are in line with the systematic review which identified 16 studies using the Pioneer RED, reporting a technical success rate of 87.4-100% (median = 100%) and complication rate of 0-25.8% (median = 0%). However, due to heterogeneity in definitions of technical success, data was not pooled.
Identifiants
pubmed: 34854997
doi: 10.1186/s42155-021-00268-w
pii: 10.1186/s42155-021-00268-w
pmc: PMC8637523
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
81Informations de copyright
© 2021. The Author(s).
Références
Cardiovasc Intervent Radiol. 1990 Dec;13(6):357-63
pubmed: 2149672
J Vasc Surg. 2021 Sep;74(3):746-755
pubmed: 33592298
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Korean Circ J. 2017 Jan;47(1):89-96
pubmed: 28154596
Rofo. 2006 Sep;178(9):898-905
pubmed: 16921463
Circulation. 1995 Mar 1;91(5):1472-9
pubmed: 7867189
Ann Vasc Surg. 2015 Jan;29(1):55-62
pubmed: 25449989
Tech Vasc Interv Radiol. 2004 Mar;7(1):23-7
pubmed: 15071777
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):495-9
pubmed: 21542103
Catheter Cardiovasc Interv. 2018 Sep 1;92(3):526-532
pubmed: 29521465
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):485-92
pubmed: 23152133
J Endovasc Ther. 2015 Aug;22(4):538-45
pubmed: 26187977
J Vasc Surg. 2006 Jun;43(6):1291-6
pubmed: 16765258
BMJ. 2012 Aug 14;345:e5208
pubmed: 22893640
Circulation. 2004 Aug 10;110(6):738-43
pubmed: 15262830
Catheter Cardiovasc Interv. 2014 May 1;83 Suppl 1:S1-S247
pubmed: 24861963
J Vasc Surg. 2003 Feb;37(2):386-91
pubmed: 12563211
Circ J. 2018 Jun 25;82(7):1900-1907
pubmed: 29681585
Tex Heart Inst J. 2011;38(4):392-7
pubmed: 21841867
EuroIntervention. 2005 May;1(1):115-9
pubmed: 19758886
Lancet. 2005 Dec 3;366(9501):1925-34
pubmed: 16325694
Circulation. 1985 Mar;71(3):510-5
pubmed: 3156006
J Vasc Surg. 2007 Jan;45 Suppl S:S5-67
pubmed: 17223489
Catheter Cardiovasc Interv. 2014 May 1;83(6):E212-20
pubmed: 24402839
J Invasive Cardiol. 2009 Sep;21(9):468-72
pubmed: 19726821
Ann Vasc Surg. 2010 May;24(4):487-97
pubmed: 20363107
J Vasc Surg. 2019 Feb;69(2):470-481.e2
pubmed: 30683195
Eur J Vasc Endovasc Surg. 2009 Sep;38(3):323-37
pubmed: 19570689
J Endovasc Ther. 2004 Jun;11(3):274-80
pubmed: 15174902
Cardiovasc Revasc Med. 2020 Jan;21(1):34-45
pubmed: 31054801